DDX 3 participates in mi RNA biogenesis and RNA interference through translational control of PACT and interaction with AGO 2
FEBS Open Bio · 2025
DOI: 10.1002/2211-5463.13920 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2025. Verfasst von Ming-Chih Lai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: DEAD-box RNA Helicases, MicroRNAs, Argonaute Proteins, RNA Interference. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Chang Gung Memorial Hospital, Taiwan, Chang Gung Memorial Hospital.
Abstract (Originalsprache)
DDX3 is a DEAD‐box RNA helicase that plays multiple roles in RNA metabolism, including translation. We previously reported that DDX3 is required for translation of PACT, a binding partner of Dicer, suggesting a role for DDX3 in microRNA (miRNA) biogenesis and RNA interference (RNAi). Emerging evidence suggests that DDX3 plays a vital role in tumorigenesis and cancer progression, however, its underlying mechanism is still not fully understood. Here, we showed that the control of PACT by DDX3 is conserved in human cells and Caenorhabditis elegans . Using a miRNA microarray, we found that DDX3 regulates the expression of a small subset of cancer‐related miRNAs. These oncogenic miRNAs were down‐regulated by knockdown of DDX3 or PACT and up‐regulated by overexpression of DDX3 or PACT in HEK293T cells. Similar results were obtained in human cancer HCT116 and HeLa cells. Dual luciferase reporter assay showed that DDX3 and PACT are required for short hairpin RNA (shRNA)‐induced RNAi. We also performed co‐immunoprecipitation to confirm the interaction between DDX3 and AGO2, a significant component of the RNA‐induced silencing complex, supporting a role for DDX3 in the RNAi pathway. We further examined the effects of DDX3 and PACT on cell proliferation, and stable overexpression of DDX3 in HEK293 cells results in loss of contact inhibition of cell growth. Hence, we propose that DDX3 may participate in cancer development by regulating the RNAi pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan.
- Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan.
- Department of Colorectal Surgery, New Taipei Municipal Tucheng Hospital, Taiwan.
- Graduate Institute of Microbiology, National Taiwan University, Taipei, Taiwan.
- Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
ORCID-Profile: Ming-Chih Lai, Shih-Peng Chan
Förderung
- National Science and Technology Council
- Chang Gung Memorial Hospital, Taiwan
- Chang Gung Memorial Hospital
Zitieren
APA
Lai, M. C., Yu, Y. L., Chen, C. N., Yu, J. S., Hung, H. Y., & Chan, S. P. (2025). DDX 3 participates in mi RNA biogenesis and RNA interference through translational control of PACT and interaction with AGO 2. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13920
Vancouver
Lai MC, Yu YL, Chen CN, Yu JS, Hung HY, Chan SP. DDX 3 participates in mi RNA biogenesis and RNA interference through translational control of PACT and interaction with AGO 2. FEBS Open Bio. 2025. doi:10.1002/2211-5463.13920
BibTeX
@article{Lai2025,
author = {Lai, Ming-Chih and Yu, Yen-Ling and Chen, Chiao-Nung and Yu, Jau-Song and Hung, Hsin-Yuan and Chan, Shih-Peng},
title = {DDX 3 participates in mi RNA biogenesis and RNA interference through translational control of PACT and interaction with AGO 2},
journal = {FEBS Open Bio},
year = {2025},
doi = {10.1002/2211-5463.13920}
}
EUVIMED